Morbidity and Mortality After Vertebral Fractures: Comparison of Vertebral Augmentation and Nonoperative Management in the Medicare Population

Study Design. Vertebral compression fracture (VCF) patients in the 100% US Medicare data set (2005–2009). Objective. To compare the mortality and morbidity risks for VCF patients undergoing conservative treatment (nonoperated), balloon kyphoplasty (BKP), and vertebroplasty (VP). Summary of Background Data. Studies have reported lower mortality risk for BKP or VP cohorts than nonoperated cohorts, but it is uncertain whether there are any differences in morbidity risks. Methods. Survival and morbidity was estimated by the Kaplan-Meier method, and the differences in outcomes were assessed by Cox regression between BKP, VP, and nonoperated cohorts. A propensity matching analysis was used to account for potential bias. Results. A total of 1,038,956 VCF patients were identified, including 141,343 BKP patients and 75,364 VP patients. The nonoperated cohort was found to have a 55% higher adjusted risk of mortality (P < 0.001) than the BKP cohort and 25% higher adjusted risk of mortality (P < 0.001) than the VP cohort. The BKP cohort was also found to have a 19% lower adjusted risk of mortality (P < 0.001) than the VP cohort. The findings were similar for mortality with pneumonia diagnosed in the 90 days before death and also after propensity matching, as well as for subgroups of osteoporotic VCF patients, including those who survived at least 1 year and those with no cancer diagnosis. With propensity matching, the nonoperated cohort had significantly higher adjusted risks of pneumonia, myocardial infarction/cardiac complications, DVT, and urinary tract infection than the BKP cohort but lower adjusted risks of subsequent augmentation/fusion, subsequent augmentation, and pulmonary/respiratory complications. The BKP cohort also had significantly lower risks of morbidity than the VP cohort, except for deep venous thrombosis (DVT), infection, and myocardial infarction/cardiac complications, which were similar between both cohorts. Conclusion. VCF patients in the Medicare population who received vertebral augmentation therapies, specifically BKP and VP, experienced lower mortality and overall morbidity than VCF patients who received conservative management. Level of Evidence: 3

[1]  R. Deyo,et al.  Treatment of osteoporotic vertebral fractures-reply. , 2014, JAMA internal medicine.

[2]  R. Skolasky,et al.  Impact of nonoperative treatment, vertebroplasty, and kyphoplasty on survival and morbidity after vertebral compression fracture in the medicare population. , 2013, The Journal of bone and joint surgery. American volume.

[3]  Brendan J. McCullough,et al.  Major medical outcomes with spinal augmentation vs conservative therapy. , 2013, JAMA internal medicine.

[4]  T. Mendoza,et al.  Vertebral compression fracture treatment with vertebroplasty and kyphoplasty: experience in 407 patients with 1,156 fractures in a tertiary cancer center. , 2011, Pain medicine.

[5]  A. Moskowitz,et al.  Kyphoplasty and vertebroplasty: trends in use in ambulatory and inpatient settings. , 2011, The spine journal : official journal of the North American Spine Society.

[6]  S. Kurtz,et al.  Mortality risk for operated and nonoperated vertebral fracture patients in the medicare population , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  D. Yan,et al.  Comparative study of percutaneous vertebroplasty and kyphoplasty in the treatment of osteoporotic vertebral compression fractures , 2011, Archives of Orthopaedic and Trauma Surgery.

[8]  C. Cooper,et al.  Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis , 2011, Osteoporosis International.

[9]  Andrew P. White,et al.  Comparison of 5766 Vertebral Compression Fractures Treated With or Without Kyphoplasty , 2010, Clinical orthopaedics and related research.

[10]  William Hollingworth,et al.  A randomized trial of vertebroplasty for osteoporotic spinal fractures. , 2009, The New England journal of medicine.

[11]  R. Buchbinder,et al.  A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. , 2009, The New England journal of medicine.

[12]  G. Gartlehner,et al.  Kyphoplastie und Vertebroplastie bei osteoporotischen Wirbelkörperkompressionsfrakturen , 2009, Der Orthopäde.

[13]  M. Quante,et al.  Comparison of kyphoplasty and vertebroplasty in the treatment of fresh vertebral compression fractures , 2009, Archives of Orthopaedic and Trauma Surgery.

[14]  Tom Stanley,et al.  Percutaneous Treatment of Vertebral Compression Fractures: A Meta-analysis of Complications , 2009, Spine.

[15]  Douglas Wardlaw,et al.  Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial , 2009, The Lancet.

[16]  S. Kurtz,et al.  Mortality following the diagnosis of a vertebral compression fracture in the Medicare population. , 2008, The Journal of bone and joint surgery. American volume.

[17]  Shih-Hao Chen,et al.  Unusual Presentation of Infected Vertebroplasty with Delayed Cement Dislodgment in an Immunocompromised Patient: Case Report and Review of Literature , 2008, CardioVascular and Interventional Radiology.

[18]  Peter C Austin,et al.  The performance of different propensity-score methods for estimating relative risks. , 2008, Journal of clinical epidemiology.

[19]  P. Stahel,et al.  Complications and safety aspects of kyphoplasty for osteoporotic vertebral fractures: a prospective follow-up study in 102 consecutive patients , 2008, Patient safety in surgery.

[20]  N. Ebraheim,et al.  Changes of Pulmonary Function for Patients With Osteoporotic Vertebral Compression Fractures After Kyphoplasty , 2007, Journal of spinal disorders & techniques.

[21]  F. McKiernan,et al.  Infected Vertebroplasty: Case Report and Review of Literature , 2006, Spine.

[22]  D. Bates,et al.  Charlson Index is associated with one-year mortality in emergency department patients with suspected infection. , 2006, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[23]  T. Diamond,et al.  Clinical outcomes after acute osteoporotic vertebral fractures: a 2‐year non‐randomised trial comparing percutaneous vertebroplasty with conservative therapy , 2006, The Medical journal of Australia.

[24]  J. Ulmer,et al.  Treating osteoporotic and neoplastic vertebral compression fractures with vertebroplasty and kyphoplasty. , 2005, Journal of palliative medicine.

[25]  J. Katz,et al.  Survival following total hip replacement. , 2005, The Journal of bone and joint surgery. American volume.

[26]  O. Johnell,et al.  Long-Term Morbidity and Mortality After a Clinically Diagnosed Vertebral Fracture in the Elderly—a 12- and 22-Year Follow-up of 257 Patients , 2005, Calcified Tissue International.

[27]  P. Mummaneni,et al.  Infected vertebroplasty. Report of two cases and review of the literature. , 2004, Neurosurgical focus.

[28]  S. Cummings,et al.  Incident vertebral fractures and mortality in older women: a prospective study , 2003, Osteoporosis International.

[29]  Michael A. Posner,et al.  Comparing Standard Regression, Propensity Score Matching, and Instrumental Variables Methods for Determining the Influence of Mammography on Stage of Diagnosis , 2001, Health Services and Outcomes Research Methodology.

[30]  H K Genant,et al.  Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. , 1999, Archives of internal medicine.

[31]  J. Eisman,et al.  Mortality after all major types of osteoporotic fracture in men and women: an observational study , 1999, The Lancet.

[32]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[33]  O. Johnell,et al.  Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: A 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study , 2003, Osteoporosis International.